跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Echinacea
首页
药物
Echinacea
Approved
Biotech
Echinacea
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
UNII ID
4N9P6CC1DX
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Combinations of extracts of Serenoa repens and lipophilic extracts of Zingiber officinalis and Echinacea angustifolia, the use thereof, and formulations containing them
US 9730974 B2
申请人: INDENA SPA
优先权: 2013
CN
EP
US
5 件公开
ECHINACEA EXTRACT AS ANTI-IRRITANT AND ANTI-AGING BOOSTER IN COSMETIC COMPOSITIONS
EP 1261315 B2
申请人: UNILEVER PLC
优先权: 2000
EP
US
WO
4 件公开
Echinacea, lavender, mastic gum and sage for treating halitosis
EP 2066304 B1
申请人: DENTAL BIOTECHNOLOGY LTD
优先权: 2006
EP
US
WO
4 件公开
Plant extract hydrolysates and antibacterial product containing the same
CN 104840490 A
申请人: BIONORICA AG
优先权: 2008
CN
US
4 件公开
Formulations containing extracts of Echinacea angustifolia and Zingiber officinale which are useful in reducing inflammation and peripheral pain
US 9283259 B2
申请人: BOMBARDELLI EZIO
优先权: 2010
CN
US
4 件公开
Compositions comprising lipophilic extracts of Zingiber officinale and Echinacea angustifolia for the prevention and treatment of gastro-oesophageal reflux and chemotherapy-induced emesis
US 8361521 B2
申请人: INDENA SPA
优先权: 2009
US
4 件公开
PHARMACEUTICAL COMPOSITIONS FOR RELIEF OF COVID-19 SYMPTOMS AND METHODS OF PRODUCING AND USING THEM
EP 4142701 A1
申请人: ZALTZMAN ZAHAVA
优先权: 2020
EP
US
WO
3 件公开
NOVEL METHODS AND COMPOSITIONS FOR TREATMENT OF DISEASE
US 2015064291 A1
申请人: IZUN PHARMACEUTICALS LTD
优先权: 2013
CN
US
3 件公开
Nutraceutical formulation for unblocking receptors
US 11219612 B2
申请人: DREMCUBED LLC
优先权: 2019
US
WO
3 件公开
Echinacea Formulation
US 2008124408 A1
申请人: MEDIHERB HOLDINGS LTD
优先权: 2004
US
3 件公开
第 1 / 10 页
上一页
下一页
药物
反馈